Skip to content

Three-dimensional Lumbar Myofascial Release and Motor Control in Lumbar Radiculopathy

Effect of Three-dimensional Lumbar Myofascial Release With Motor Control Training on Back Perception and Pain in Patients With Lumbar Radiculopathy

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06990113
Enrollment
40
Registered
2025-05-25
Start date
2025-06-01
Completion date
2026-07-15
Last updated
2026-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar Radiculopathy

Brief summary

to investigate The Efficacy of three-dimensional lumbar myofascial release with motor control training on back perception and pain in lumbar radiculopathy Patients with lumbar radiculopathy demonstrate impairments in function and range of motion to deficits in patient's quality of life.

Detailed description

PURPOSE: to investigate The Efficacy of three-dimensional lumbar myofascial release with motor control training on back perception and pain in lumbar radiculopathy Patients with lumbar radiculopathy demonstrate impairments in function and range of motion to deficits in patient's quality of life. HYPOTHESES: It will be hypothesized that there will be no statically Effect of three dimensional lumbar myofascial release with motor control training on back perception and pain in lumbar radiculopathy RESEARCH QUESTION: Is there an Effect of three-dimensional lumbar myofascial release with motor control training on back perception and pain in lumbar radiculopathy

Interventions

OTHERthree dimensional lumbar myofascial release

Three-dimensional (3D) MFR is a novel approach toward reducing fascial restrictions. It recognizes that fascia exists not only in a linear plane but also in complex multidirectional networks throughout the body.

conventional treatment, including selected physical therapy, flexibility exercise for the back, static back and abdomen exercises, and electrotherapy

Sponsors

October 6 University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

The patients were randomly divided into two equal groups; Study group (16 patients): received three dimensional lumbar myofascial release with motor control training, and conventional treatment. Control group (16 patients): received conventional treatment.

Eligibility

Sex/Gender
ALL
Age
35 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Their ages range from 35 to 50 years. * Both sex * Unilateral lumbar radiculopathy for more than 6 months. * Normal body mass index (18.5 - 24.99Kg/m2).

Exclusion criteria

* • Any other musculoskeletal disorders of the spine or upper extremity * Patients with any other Neurological deficits, psychiatric disease lumbar myelopathy, Cognitive problems, vertebral fractures and previous history of spine or lumbar surgery. * Clinical instability, recent trauma * Structural abnormalities of the spine, osteoporosis, and spasmodic torticollis. * Inflammatory or other specific disorders of spina such as ankylosing spondylitis and rheumatoid arthritis

Design outcomes

Primary

MeasureTime frameDescription
Fremantle Back Awareness Questionnairefour weeksThe Fremantle Back Awareness Questionnaire (FreBAQ) has been found to possess adequate psychometric properties in low back pain (LBP) patients worldwide
Oswestry Low Back Pain Disability Questionnairefour weeksThe Oswestry Disability Index (ODI) a patient-completed questionnaire which gives a subjective percentage score of level of function (disability) in activities of daily living in those rehabilitating from low back pain

Secondary

MeasureTime frameDescription
pressure pain algometerfour weeksAlgometers are designed to quantify and document levels of tenderness via pressure pain threshold measurement and pain sensitivity via pressure pain tolerance measurement.
visual analog scalefour weeksThe pain VAS is a unidimensional measure of pain intensity, used to record patients' pain progression, or compare pain severity between patients with similar conditions

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 26, 2026